Antibe Therapeutics Inc.
TSX:ATE.TO
0.295 (CAD) • At close April 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||
Current Assets: | ||||||||||||
Cash & Cash Equivalents
| 6.755 | 34.807 | 71.973 | 6.182 | 5.993 | 3.726 | 1.502 | 0.386 | 0.397 | 3.755 | 0.194 | 0.093 |
Short Term Investments
| 32.137 | 20 | 0.025 | 0.025 | 0.025 | 0.025 | 0.025 | 0.025 | 0.025 | 0 | 0 | 0 |
Cash and Short Term Investments
| 38.892 | 54.807 | 71.998 | 6.207 | 6.018 | 3.751 | 1.527 | 0.411 | 0.422 | 3.755 | 0.194 | 0.093 |
Net Receivables
| 1.615 | 1.121 | 2.584 | 1.694 | 1.567 | 1.267 | 1.181 | 1.496 | 0.264 | 0.473 | 0.217 | 0.018 |
Inventory
| 0.001 | 0.001 | 2.157 | 3.424 | 2.803 | 3.106 | 2.753 | 2.374 | 0.018 | 0 | 0 | 0 |
Other Current Assets
| 1.038 | 5.436 | 2.364 | 0.182 | 0.175 | 0.186 | 0.025 | 0.025 | 0.025 | 0.124 | 0.046 | 0.003 |
Total Current Assets
| 41.546 | 61.364 | 79.103 | 11.507 | 10.564 | 8.311 | 6.223 | 5.011 | 0.729 | 4.352 | 0.457 | 0.115 |
Non-Current Assets: | ||||||||||||
Property, Plant & Equipment, Net
| 0 | 0 | 0.309 | 0.303 | 0.181 | 0.094 | 0.075 | 0.08 | 0 | 0 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 1.283 | 1.283 | 1.283 | 1.283 | 0 | 0 | 0 | 0 |
Intangible Assets
| 26.352 | 26.352 | 0.869 | 1.771 | 2.434 | 2.78 | 3.125 | 3.215 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 26.352 | 26.352 | 0.869 | 1.771 | 3.717 | 4.063 | 4.409 | 4.499 | 0 | 0 | 0 | 0 |
Long Term Investments
| -32.105 | -19.98 | -0.025 | -0.025 | 0.1 | 0 | 0 | 0.007 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 1.486 | 0.281 | 0.261 | 0 | 0 | 0.125 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 34.768 | 21.422 | -0.001 | 0.001 | -0.004 | 0.023 | 0.018 | 0.018 | 0.061 | 0 | 0.281 | 0.056 |
Total Non-Current Assets
| 29.015 | 27.794 | 2.638 | 2.331 | 4.255 | 4.18 | 4.502 | 4.73 | 0.061 | 0 | 0.281 | 0.056 |
Total Assets
| 70.561 | 89.158 | 81.741 | 13.838 | 14.819 | 12.491 | 10.726 | 9.74 | 0.789 | 4.352 | 0.738 | 0.171 |
Liabilities & Equity: | ||||||||||||
Current Liabilities: | ||||||||||||
Account Payables
| 0.003 | 0.003 | 2.33 | 0.004 | 0.002 | 1.472 | 0 | 0 | 0.427 | 0.474 | 0.537 | 0.136 |
Short Term Debt
| 0 | 0 | 0.133 | 2.333 | 0 | 1.537 | 1.152 | 1.643 | -0.025 | 0.109 | 0.762 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 1.278 | 5.254 | 0 | 0 | 0 | 0 | 0.025 | 0.225 | 0 | 0 |
Other Current Liabilities
| 2.761 | 4.691 | 0 | 0.004 | 2.904 | 0.423 | 1.995 | 1.362 | 0.025 | 0.225 | 0 | 0.261 |
Total Current Liabilities
| 2.764 | 4.694 | 3.741 | 7.595 | 2.907 | 3.432 | 3.147 | 3.005 | 0.452 | 1.033 | 1.299 | 0.397 |
Non-Current Liabilities: | ||||||||||||
Long Term Debt
| 0 | 0 | 0.105 | 0.065 | 2.072 | 0 | 2.632 | 2.027 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 27.631 | 27.631 | 27.631 | 2.399 | 2.399 | 1.084 | 1.084 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | -0.028 | -0.002 | 0.002 | 0 | 0.31 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0.028 | 0.002 | -0.002 | 0 | 0 | 0 | 0 | 0 | 0.446 | 0 |
Total Non-Current Liabilities
| 27.631 | 27.631 | 27.736 | 2.464 | 4.472 | 1.084 | 4.025 | 2.027 | 0 | 0 | 0.446 | 0 |
Total Liabilities
| 30.395 | 32.325 | 31.477 | 10.059 | 7.378 | 4.516 | 7.172 | 5.033 | 0.452 | 1.033 | 1.745 | 0.397 |
Equity: | ||||||||||||
Preferred Stock
| 0 | 0 | 0 | 13.758 | 10.788 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 141.489 | 139.547 | 111.574 | 49.666 | 36.986 | 29.507 | 15.518 | 13.113 | 8.238 | 7.206 | 1.372 | 1.32 |
Retained Earnings
| -130.491 | -111.016 | -85.956 | -59.673 | -40.332 | -27.516 | -20.086 | -13.606 | -10.975 | -6.574 | -3.894 | -2.849 |
Accumulated Other Comprehensive Income/Loss
| 10.264 | 10.264 | 10.353 | 0.018 | -0.005 | 0.002 | 0.029 | 0.022 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 18.904 | 18.038 | 14.293 | 0.01 | 0.003 | 5.981 | 8.092 | 5.179 | 3.075 | 2.687 | 1.515 | 1.303 |
Total Shareholders Equity
| 40.166 | 56.833 | 50.264 | 3.779 | 7.441 | 7.975 | 3.553 | 4.708 | 0.337 | 3.319 | -1.007 | -0.226 |
Total Equity
| 40.166 | 56.833 | 50.264 | 3.779 | 7.441 | 7.975 | 3.553 | 4.708 | 0.337 | 3.319 | -1.007 | -0.226 |
Total Liabilities & Shareholders Equity
| 70.561 | 89.158 | 81.741 | 13.838 | 14.819 | 12.491 | 10.726 | 9.74 | 0.789 | 4.352 | 0.738 | 0.171 |